it is trial in which a drug will be administered to the patient and its effect will be seen on reduction in post operative infection.

A Randomized Control trial to evaluate the role/efficacy of single dose intravenous Tranexamic acid at the time of induction of anesthesia for post operative seroma formation in para-umbilical hernioplasty at a tertiary care center - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/11/076136

Enrollment

Registered

2024-11-01

Start date

Unknown

Completion date

Unknown

Last updated

2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: 3- Administration

Interventions

Intervention1: Intravenous Tranexamic acid: 1 gram of Intravenous tranexamic acid given during the induction of anaesthesia Control Intervention1: not applicable: not applicable

Eligibility

Inclusion criteria

Inclusion criteria: UNCOMPLICATED PARA-UMBILICAL HERNIAS AND AGES BETWEEN 18-70 YEARS

Exclusion criteria

Exclusion criteria: Complicated/Strangulated Hernias, Hernias Associated with medical diseases affecting coagulation profile ,chronic renal insufficiency or failure , color or vision disorders, history of thrombo-embolic events, pregnant/lactating women.

Design outcomes

Primary

Measure	Time frame
Post operative decrease in seroma formation by reducing drain output.Timepoint: Post operative drain output will be measured on day 1, day 3 and day 5.	—

Secondary

Measure	Time frame
IV tranexamic acid can cause adverse drug reactionTimepoint: on the time of administration	—

Countries

India

Contacts

Public ContactDr BM Kajagar

KLE Academy of higher education and research

bmkajagar@rediffmail.com8722630285

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026